<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article"><?properties open_access?><!-- Original-type: ra--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10362116</article-id><article-id pub-id-type="pmc">2363039</article-id><article-id pub-id-type="pii">6690463</article-id><article-id pub-id-type="doi">10.1038/sj.bjc.6690463</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Article</subject></subj-group></article-categories><title-group><article-title>Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ghielmini</surname><given-names>M</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pagani</surname><given-names>O</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Jong</surname><given-names>J de</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Pampallona</surname><given-names>S</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Conti</surname><given-names>A</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Maestroni</surname><given-names>G</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Sessa</surname><given-names>C</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Cavalli</surname><given-names>F</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Servizio Oncologico Cantonale, Ospedale San Giovanni, 6500 Bellinzona, Switzerland</aff><aff id="aff2"><label>2</label>Istituto Patologico Cantonale, 6600 Locarno, Switzerland</aff><aff id="aff3"><label>3</label>Formed, Statistics for Medecine, 1983 Evol&#x000e8;ne, Switzerland</aff><pub-date pub-type="ppub"><month>06</month><year>1999</year></pub-date><volume>80</volume><issue>7</issue><fpage>1058</fpage><lpage>1061</lpage><history><date date-type="received"><day>28</day><month>07</month><year>1998</year></date><date date-type="rev-recd"><day>27</day><month>11</month><year>1998</year></date><date date-type="accepted"><day>04</day><month>12</month><year>1998</year></date></history><copyright-statement>Copyright 1999, Cancer Research Campaign</copyright-statement><copyright-year>1999</copyright-year><permissions><copyright-holder>Cancer Research Campaign</copyright-holder></permissions><kwd-group><kwd>myelotoxicity</kwd><kwd>chemotherapy</kwd><kwd>hormones</kwd><kwd>melatonin</kwd></kwd-group></article-meta></front></article>


